Atazanavir Sulfate Patent Expiration
Atazanavir Sulfate is Used for treating HIV-1 infection. It was first introduced by Bristol Myers Squibb Co
Atazanavir Sulfate Patents
Given below is the list of patents protecting Atazanavir Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Reyataz |
US6087383 (Pediatric) | Bisulfate salt of HIV protease inhibitor |
Jun 21, 2019
(Expired) | Bristol Myers Squibb |
| Reyataz | US6087383 | Bisulfate salt of HIV protease inhibitor |
Dec 21, 2018
(Expired) | Bristol Myers Squibb |
| Reyataz | US6087383 | Bisulfate salt of HIV protease inhibitor |
Dec 21, 2018
(Expired) | Bristol Myers Squibb |
| Reyataz |
US5849911 (Pediatric) | Antivirally active heterocyclic azahexane derivatives |
Dec 20, 2017
(Expired) | Bristol Myers Squibb |
| Reyataz | US5849911 | Antivirally active heterocyclic azahexane derivatives |
Jun 20, 2017
(Expired) | Bristol Myers Squibb |
| Reyataz | US5849911 | Antivirally active heterocyclic azahexane derivatives |
Jun 20, 2017
(Expired) | Bristol Myers Squibb |
Atazanavir Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List